Publications by authors named "Marion Decreuse"
Article Synopsis
- Molecular targeted therapy for metastatic melanoma is generally safer than chemotherapy but can still cause serious side effects, including life-threatening toxicity.
- A case study is reported where a patient treated with dabrafenib and trametinib experienced intracranial hemorrhage.
- Physicians need to be vigilant about this rare complication, ensuring the source of bleeding is correctly identified, as it may indicate new melanoma metastasis, anticoagulation overdose, or uncontrolled high blood pressure.
